Timothy A. Springer - Oct 2, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Stock symbol
RNAC
Transactions as of
Oct 2, 2024
Transactions value $
$4,293,545
Form type
4
Date filed
10/4/2024, 05:58 PM
Previous filing
Sep 27, 2024
Next filing
Oct 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Other +1.8M +29.94% 7.82M Oct 2, 2024 Direct F1
transaction RNAC Common Stock Purchase $95.8K +5.51K +0.07% $17.38 7.82M Oct 2, 2024 Direct F2
transaction RNAC Common Stock Other -2.12M -80% 530K Oct 2, 2024 See Footnote F1, F3
transaction RNAC Common Stock Other +318K +2480.33% 331K Oct 2, 2024 By wife F1
transaction RNAC Common Stock Purchase $545K +29.8K +0.38% $18.25 7.85M Oct 3, 2024 Direct F4
transaction RNAC Common Stock Purchase $195K +10.2K +0.13% $19.01 7.86M Oct 3, 2024 Direct F5
transaction RNAC Common Stock Purchase $1.02M +50.5K +0.64% $20.18 7.91M Oct 3, 2024 Direct F6
transaction RNAC Common Stock Purchase $451K +21.3K +0.27% $21.17 7.94M Oct 3, 2024 Direct F7
transaction RNAC Common Stock Purchase $176K +8.04K +0.1% $21.86 7.94M Oct 3, 2024 Direct F8
transaction RNAC Common Stock Purchase $211K +9.89K +0.12% $21.35 7.95M Oct 4, 2024 Direct F9
transaction RNAC Common Stock Purchase $1.09M +48.9K +0.61% $22.35 8M Oct 4, 2024 Direct F10
transaction RNAC Common Stock Purchase $392K +16.7K +0.21% $23.57 8.02M Oct 4, 2024 Direct F11
transaction RNAC Common Stock Purchase $117K +4.88K +0.06% $23.93 8.02M Oct 4, 2024 Direct F12

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Warrant (Right to Buy) Other -134K -80% 33.4K Oct 2, 2024 Common Stock 134K $46.50 See Footnote F1, F3
transaction RNAC Warrant (Right to Buy) Other +114K 114K Oct 2, 2024 Common Stock 114K $46.50 Direct F1
transaction RNAC Warrant (Right to Buy) Other +20K 20K Oct 2, 2024 Common Stock 20K $46.50 By wife F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution for no consideration from TAS Partners LLC to the reporting person or the reporting person's spouse, as the case may be. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
F2 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.17 to $17.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
F4 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.76 to $18.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $18.76 to $19.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $19.77 to $20.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.78 to $21.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F8 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.80 to $22.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F9 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $20.87 to $21.86. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $21.87 to $22.8626. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F11 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $22.87 to $23.8699. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F12 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $23.87 to $24.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.